High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate
- 308 Downloads
The US Environmental Protection Agency (EPA) launched the Transform Tox Testing Challenge in 2016 with the goal of developing practical methods that can be integrated into conventional high-throughput screening (HTS) assays to better predict the toxicity of parent compounds and their metabolites in vivo. In response to this need and to retrofit existing HTS assays for assessing metabolism-induced toxicity of compounds, we have developed a 384-pillar plate that is complementary to traditional 384-well plates and ideally suited for culturing human cells in three dimensions at a microscale. Briefly, human embryonic kidney (HEK) 293 cells in a mixture of alginate and Matrigel were printed on the 384-pillar plates using a microarray spotter, which were coupled with 384-well plates containing nine model compounds provided by the EPA, five representative Phase I and II drug metabolizing enzymes (DMEs), and one no enzyme control. Viability and membrane integrity of HEK 293 cells were measured with the calcein AM and CellTiter-Glo® kit to determine the IC50 values of the nine parent compounds and DME-generated metabolites. The Z′ factors and the coefficient of variation measured were above 0.6 and below 14%, respectively, indicating that the assays established on the 384-pillar plate are robust and reproducible. Out of nine compounds tested, six compounds showed augmented toxicity with DMEs and one compound showed detoxification with a Phase II DME. This result indicates that the 384-pillar plate platform can be used to measure metabolism-induced toxicity of compounds in high-throughput with individual DMEs. As xenobiotics metabolism is a complex process with a variety of DMEs involved, the predictivity of our approach could be further improved with mixtures of DMEs.
Keywords384-Pillar plate Metabolism-induced toxicity Transform Tox Testing Challenge Three-dimensional (3D) cell culture High-throughput screening
This study was partially supported by the US Environmental Protection Agency (US EPA Transform Tox Testing Challenge), Medical & Bio Device (MBD) Korea, the Cleveland State University (Faculty Innovation Fund), and the National Institutes of Health (NIEHS R01ES025779). We also acknowledge Dr. Kevin Kuhn at the US EPA and Mr. Rayton Gerald at 3D MicroArray, Inc. for their guidance and help during the Transform Tox Testing Challenge.
Compliance with ethical standards
Conflict of interest
The authors declare a potential conflict of interest as the 384-pillar plates manufactured by their industrial partner, Medical and Bio Device (MBD) Korea, have been used in this study.
- Ekhart C, Doodeman VD, Rodenhuis S, Smits PH, Beijnen JH, Huitema AD (2008) Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide. Pharmacogenet Genom 18(6):515–523. https://doi.org/10.1097/FPC.0b013e3282fc9766 CrossRefGoogle Scholar
- Gundert-Remy U, Bernauer U, Blömeke B, Döring B, Fabian E, Goebel C, Hessel S, Jäckh C, Lampen A, Oesch F, Petzinger E, Völkel W, Roos PH (2014) Extrahepatic metabolism at the body’s internal-external interfaces. Drug Metab Rev 46(3):291–324. https://doi.org/10.3109/03602532.2014.900565 CrossRefGoogle Scholar
- Gupta RC (ed) (2012) Veterinary toxicology: basic and clinical principles. Academic Press, AmsterdamGoogle Scholar
- Lee MY (ed) (2017) Microarray bioprinting technology: fundamentals and practices. Springer, BerlinGoogle Scholar
- Mironov SL, Ivannikov MV, Johansson M (2005) [Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release. J Biol Chem 280(1):715–721. https://doi.org/10.1074/jbc.M409819200 CrossRefPubMedGoogle Scholar
- Raccor BS, Claessens AJ, Dinh JC, Park JR, Hawkins DS, Thomas SS, Makar KW, McCune JS, Totah RA (2012) Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo. Drug Metab Dispos 40(1):54–63. https://doi.org/10.1124/dmd.111.039347 CrossRefPubMedPubMedCentralGoogle Scholar
- Richard AM, Judson RS, Houck KA, Grulke CM, Volarath P, Thillainadarajah I, Yang C, Rathman J, Martin MT, Wambaugh JF, Knudsen TB, Kancherla J, Mansouri K, Patlewicz G, Williams AJ, Little SB, Crofton KM, Thomas RS (2016) ToxCast chemical landscape: paving the road to 21st century toxicology. Chem Res Toxicol 29(8):1225–1251. https://doi.org/10.1021/acs.chemrestox.6b00135 CrossRefPubMedGoogle Scholar
- Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L (2013) Cell viability assays [Updated 2016 Jul 1]. In: Sittampalam GS,Coussens NP, Brimacombe K et al (eds) Assay Guidance Manual [Internet]. Eli Lilly and Company and the National Center for Advancing Translational Sciences, Bethesda, MD. Available from: https://www.ncbi.nlm.nih.gov/books/NBK144065/ Google Scholar
- Vijayakumar TM, Kumar RM, Agrawal A, Dubey GP, Ilango K (2015) Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening. J Food Sci Technol 52(7):4537–4543. https://doi.org/10.1007/s13197-014-1472-x CrossRefPubMedGoogle Scholar
- Yu KN, Nadanaciva S, Rana P, Lee DW, Ku B, Roth AD, Dordick JS, Will Y, Lee MY (2017) Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays. Arch Toxicol 92(3):1295–1310. https://doi.org/10.1007/s00204-017-2126-3 CrossRefPubMedGoogle Scholar
- Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K-I, Tallman MN, Brouwer KLR (2006) Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 27(5):447–486. https://doi.org/10.1016/j.ejps.2005.12.007 CrossRefPubMedGoogle Scholar
- Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D, Berthou F (1997) Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem Res Toxicol 10(10):1205–1212. https://doi.org/10.1021/tx970048z CrossRefPubMedGoogle Scholar